highly significantp < 0.01
The highly significant hazard ratio of 3.6 ( p < 0.01) indicates a markedly faster progression rate in the high-risk group compared to the moderate/low-risk group (Fig. 4b ).
The highly significant hazard ratio of 3.6 ( p < 0.01) indicates a markedly faster progression rate in the high-risk group compared to the moderate/low-risk group (Fig. 4b ).
We attribute this to the relatively smaller sample size of patients taking SGLT2i in the future CKD group compared to the future non-CKD group ( n = 16 vs n = 23), causing the effects within the future CKD group to be non-significant but approaching significance ( p < 0.1).
Although the effects in the future CKD group were not statistically significant but near significance ( p < 0.1, Table 6) , there was a noticeable trend involving the same lipid metabolism GMF.